It is presently unknown whether the significantly different percentages of G8+/noggin+/BF+ cells in RC13 and RD RMS cells in vitro reflects the aggressiveness of ARMS and ERMS tumors in vivo. The gene discussed is SNHG32; the disease is embryonal rhabdomyosarcoma.